Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by kingbearon Mar 12, 2019 11:26am
111 Views
Post# 29473151

RE:RE:This Company needs to name a CEO

RE:RE:This Company needs to name a CEOLOL, have you seen the movement of other Cannabis stocks these last weeks?? ACB is somehow touting 700,000KG of capacity and has seen their market cap increase by 2B in the last 2 weeks alone. VFF is on a 300% run and they have not sold any actual cannabis yet. CRON is trading at a 10B valuation on 4M sales. It's only Aphria that trades like total cr ap. 
bionicjoe wrote:
kingbear wrote: ASAP. The Sp will continue to dwindle in no man's land until they have a full C-Suite. All the big names are up 3%, Aphria can barely hold 1%. Aphria is down 4% since the Aphria One approval. This will continue until a new CEO is named. Not sure what Irwin and Jakob are thinking but still not one single interview since last Monday's news which is unbelievable.


I agree they need to put in place a CEO asap. But not just any plain old CEO but one that has exceptional international marketing skills and is comfortable doing interviews with the media. It's the last piece of unfinished business that needs to be taken care of from the days of the old regime. I'm not sure we can blame all of the modest sp movement on the issue of who is going to head this company for the immediate future. To me anyway it appears the market has gravitated to show me the money and less to bidding up a cannabis stock on sheer potential or on some unfounded rumor. It's only a few months that have passed since a lot of investors got burnt from trusting in the hype so the market might just be tempering its expectations when dealing with the cannabis stocks at this stage of their development. 


Bullboard Posts